chrisvoncsefalvay/vaers-outcomes huggingface dataset:
i no longer have this crud running around and through my body and it has to have been from the vaccines; i no longer have this crud running around and through my body and it has to have been from the vaccines; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64-year-old female patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "fibroid tumors" (unspecified if ongoing), notes: I went through when I was pregnant in 1990. And I was carrying a baby and fibroid tumors; "surgery removed my uterus, ovaries, Fallopian tubes, and cervix" (unspecified if ongoing), notes: My tumors grew so painful, surgery removed my uterus, ovaries, Fallopian tubes, and cervix; "Pregnancy", start date: 1990 (unspecified if ongoing), notes: I went through when I was pregnant in 1990. And I was carrying a baby and fibroid tumors; "I had been in an accident" (unspecified if ongoing), notes: I had been in an accident at work and also had severe food poisoning close to this time; "had severe food poisoning close to this time" (unspecified if ongoing), notes: I had been in an accident at work and also had severe food poisoning close to this time. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, SINGLE; Manufacturer unknown), for Covid-19 immunization; Covid-19 vaccine (DOSE 2, SINGLE; Manufacturer unknown), for Covid-19 immunization; Covid-19 vaccine (DOSE 3 (BOOSTER), SINGLE; Manufacturer unknown), for Covid-19 immunization; Covid-19 vaccine (DOSE 4 (BOOSTER), SINGLE; Manufacturer unknown), for Covid-19 immunization. The following information was reported: PRE-EXISTING CONDITION IMPROVED (non-serious), THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown" and all described as "i no longer have this crud running around and through my body and it has to have been from the vaccines". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: "I just wanted to let y'all know that y'all may have stumbled upon a way to cure people like me. Maybe prevent theirs from developing into cancer-which is what I was terrified was going to happen to me".  Follow-up attempts are completed. No further information is expected.
1. Rash on chest with pustules 2. Headache lasting all day 12/28/2013 unrelieved by Tylenol
Breakthrough case admission after 2 vaccines Moderna 2/4/21 lot# 007M20A; Moderna 3/4/21 lot# 023M20A
Felt the medicine go through arm and hands. Right eye dropped. Rash and welts on face, neck, arms, chest and stomach. Felt like sunburn rolling around in fiberglass. Felt like thousands of needles pricking were the rash and welts were.  Went to the emergency room. Took Benedryl at home.  Advised not to take 2nd shot or to take 2nd shot with epipen. Memory fog. Ringing in right ear.
chills, fever  body aches  tinnitus  nausea    There was a dosing error.   2.5 ml given (whole vial)  instead of  0.5 ml
Headache, Fever, fatigue, chills, lower backpain, pain left upper back and injection site Narrative:
Pt c/o difficulty breathing, esophageal spasms, severe coughing for hours during the night; resolved by 1400 on 3/15/21. 98% sat on ra; increased RHR of 86 bpm (normal is 48-52bpm) -
Hands and feet are tingling; Burning; Kind of red underneath/face is kind of red; Whole back broke out last night; Rash; Itching on the palms of hands and feet/Itching on her back; Kind of like Dermatitis; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching on the palms of hands and feet/Itching on her back), PARAESTHESIA (Hands and feet are tingling), BURNING SENSATION (Burning), ERYTHEMA (Kind of red underneath/face is kind of red) and MUSCULOSKELETAL DISCOMFORT (Whole back broke out last night) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009D21A and 049C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Dermatitis (Did not have a flare up In years- probably 3 years ago was the last one.).   On 23-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching on the palms of hands and feet/Itching on her back), PARAESTHESIA (Hands and feet are tingling), BURNING SENSATION (Burning), ERYTHEMA (Kind of red underneath/face is kind of red), MUSCULOSKELETAL DISCOMFORT (Whole back broke out last night), DERMATITIS (Kind of like Dermatitis) and RASH (Rash). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL) at a dose of 1 dosage form. At the time of the report, PRURITUS (Itching on the palms of hands and feet/Itching on her back), PARAESTHESIA (Hands and feet are tingling), BURNING SENSATION (Burning), ERYTHEMA (Kind of red underneath/face is kind of red), MUSCULOSKELETAL DISCOMFORT (Whole back broke out last night), DERMATITIS (Kind of like Dermatitis) and RASH (Rash) outcome was unknown.            No relevant concomitant medications were reported.   This case was linked to MOD-2021-238686 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Additional document received: Updated patient demographics, Added new event rash, back discomfort, redness, burning sensation, tingling feet/ hands
after a PPD TB test (06/23/2020), results were negative, but I developed a rash near the test site on my arm, and on the left side of my torso; also, muscular pain in my arm, which has steadily worsened. I had a similar experience after MMR vaccine in august 2020.
Mother went by office on April 26 stating that the patient also had debilitating symptoms and body pain just like her sister. And continues with symptoms. Not been medically evaluated. Mother is counsel  to do so.
very slight and brief light headedness; This is a spontaneous report received from a contactable consumer. A 79years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration on the left arm on 20Mar2021(at the age of 79 years-old) at 13:15  as single dose for COVID-19 immunisation. Medical history of the patient included high blood pressure. Concomitant medications were not  reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  The patient experienced light headedness on 20Mar2021 at 13:15. The patient reported as very slight and brief light headedness right after administration of vaccine. The patient did not receive treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of dizziness was recovered on an unknown date in Mar2021.  Information about lot/batch number cannot be obtained. No further information is expected.
Reportedly developed a fever and vomited -temperature was not taken but mom states ''felt very warm''.Symptoms developed a few hours after receiving first Hep A vaccine, mom declines any further Hep A vaccine to be given.
Woke up the day after shot with sore arm, aches, low grade fever, fatigue, sore arm, and chills.  The following day everything was gone except the sore arm.  1/2 through the day injection site started itching/burning and rash began to form.
Date of symptom onset ? 1.13.21?  Symptoms - ? around 3:00 pm EE reports feelings of fatigue and ? felt off.?  At approx. 0330 (1/14), + fever (Tmax 100.4), resolution of fever with 400 mg of motrin.  Temp 98.2 at time of call (07:30). Last day of work and shift - ? today Home remedies? -   motrin 400 mg at 0700 Any improvement? - yes Recommendation? EE encouraged to continue to monitor symptoms and to contact EH vaccine support line with further questions or concerns.  EE asked if she was able to attend work as she had a fever this am.  EE notified of changes in the Redcap survey and verbalized back understanding.  EE denied further questions at this time.
This spontaneous report as received from a medical assistant via company representative refers to a male patient of unknown age. Pertinent medical history and drug reactions/allergies were not reported. On 05/02/2013 at 12:30 PM, the reporter stated that a patient received ZOSTAVAX vial 19400 plaque-forming units (PFU) (frequency, therapy rout Lot number and expiration date were not reported) on an unspecified date and developed "redness of the arm after receiving the shot that lasted about a day". Treatment and laboratories diagnostics neither were not reported. Additional information is not expected.
HOSPITALIZED FOR COVID19+ RESP DISTRESS HYPOXIA    RESIDENT OF NURSING HOME   SATURATING IN 70'S ON 4 L/MIN OXYGEN PER NASAL CANNULA   NOW ON Acute hypoxic hypercapnic respiratory failure  - On BiPAP FiO2 35%  - Oxygen saturation high 90s
I experienced inappropriate sinus tachycardia 2.5 months after receiving the second vaccine.  I cannot say if the events or related or not.  No treatment to-date, still in the investigation stage.  I have since had 1 other "event" on June 15th.
48 hrs after vaccine give, developed hives on right arm, soreness in arm into axilla, feeling of cold.  Sister also received vaccine at a different facility and had same symptoms Patient received influenza vaccine a week earlier from a different clinic.
This spontaneous report was received from a nurse practitioner refers to an unknown number of patients. The nurse practitioner reported that an unknown number of doses of GARDASIL that were improperly stored at -5 degrees centigrade for 1 to 2 months, may have been administered. No concomitant medications were reported. No adverse effect was reported. It was unknown if the patients sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Enlarged and painful axillary lymph node on the left side (injection site side) lasting for 5+ days. Still occurring but slowly resolving. Two days later (1 week after vaccination) injection site red and swollen for 2 days, but has since resolved.
Began feeling ill within 2-3 hours of shot. Unable to focus on work by 4th hour. Went home and slept for 3 hours. Could barely eat some dry toast. Went to bed around 8 that night (2 hours earlier than usual). Slept until 11 AM the following morning (4 hours longer than usual). Managed to eat toast successfully but appetite was non-existent until following day. Sluggish behavior following two days after recovery.
Jaw pain/tightness on right side. Went to dentist to check if it was tooth related and it was not.   I had to open and close my jaw multiple times to ?loosen? it up and the pain/tightness subsided. Lasted for about 3 1/2 weeks.
; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Refrigeration excursions identified/vaccines have undergone several temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (Vaccines undergone several temperature excursions and have been administered to patient) and NO ADVERSE EVENT (No adverse event) in a 52-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7146B) for COVID-19 prophylaxis.     No Medical History information was reported.       For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Refrigeration excursions identified/vaccines have undergone several temperature excursions) and POOR QUALITY PRODUCT ADMINISTERED (Vaccines undergone several temperature excursions and have been administered to patient).    No concomitant medication was provided.    Date vial was moved from freezer to refrigerator on 7-Sep-2022. The 2 unbroken cartons 20 vials.  It was reported that refrigeration excursions identified, state vaccine was housed in these units. There were excursions noted. Manufactures were notified and the state department and made aware of the situation. The clinic had a similar issue with vaccines stored in their freezer. Vaccines stored in the refrigerator that underwent several temperature excursions going back to August 2022. It was reported that no adverse reactions were reported to their knowledge for any patients.  Treatment medication was not provided by the reporter
I got the vaccine with the booster last year. I now have shingles/despite the shot/ Suspected vaccination failure; I now have shingles on my back and side; Worst pain ever; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, less than 2 years after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure and pain were unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine.  Additional details were reported as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. In 2020, last year, the patient received Shingles vaccine with the booster and at the time of reporting, he/she had shingles on back and side. The patient stated that he/she had worst pain ever. This case was considered as suspected vaccination failure as detail regarding laboratory test confirming herpes zoster was unknown at the time of reporting. The follow-up would not possible as no contact details were available.
Within a minute or two my heart started beating fast and hard and a headache began in my forehead. I took off my mask, rolled down the window. This helped and it subsided within the 15 minute wait when we left the vaccination site. My head continued to feel a little woozy and the hard fast heartbeat returned with the headache three more times throughout the day with last one around 5:30pm. Next day just felt washed out.
No adverse effects reported.; patient were vaccinated with improperly stored MMR II; Information has been received from a nurse referring to a 19 months old patient of unknown gender. Concomitant therapy included sterile diluent. The patient's drug reactions/allergies and pertinent medical history were not provided.  On 20-MAR-2019, the patient was vaccinated with improperly stored mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) lot # R028003, expiration date 01-OCT-2020 for prophylaxis (strength, dose, frequency and route were not provided). The sterile diluent used to reconstitute mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) was stored properly. The outcome of the event was unknown. The storage temperatures of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) was reported as -11.9 degrees Celcius for a time frame of 1 hour and 45 minutes. There was no previous temperature excursion. The call was due to a data logger. No adverse effects reported. No product quality compliance provided.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1904USA004568: US-009507513-1904USA004569: US-009507513-1904USA004570: US-009507513-1904USA004571: US-009507513-1904USA004572:
This spontaneous report as received from a nurse practitioner refers to a 60 years old male patient with a history of depression and allergy to sulfur, SSRI (selective serotonin re-uptake inhibitors) drug class and gluten. In September 2012, the patient was administered a first dose of GARDASIL intramuscularly dose 0.5 ml and the second dose of GARDASIL intramuscularly dose 0.5 ml (lot # 0101AE, expiration 10-OCT-2012) was given on 05-OCT-2012 for the treatment of warts. Other co-suspects were not reported. Concomitant medications were reported as none. It was reported that the patient stated that 6 to 7 days (approximately 11-OCT-2012) after receiving the second dose of GARDASIL, the patient experienced 3 fainting episodes. No treatment information was reported. Lab diagnostic studies performed were reported as none. On an unknown date in 2012, the patient was recovered from 3 fainting episodes. The relatedness of 3 fainting episodes was unknown for GARDASIL. Additional information has been requested.
Swelling, redness, heat, and hardness in large circle around injection site. Total redness site was approx 7-8 inches in diameter.
patient called and said that he has shoulder pain since he got his covid vaccine on 6/25/21.  The pain continues, so he went to see his doctor on 1/10/22 and was told that he has shoulder injury related to vaccine administration.  However, he is not taking any medication right now.
This spontaneous report as received from a register nurse refers to a 3 months infant, of unknown gender. Medical history and concurrent conditions were not reported. On 17-JAN-2014, the patient was vaccinated with dose 1 of ROTATEQ lot #J007283; expiration date: 27-SEP-2014 (dose, strength and route were not reported). Secondary and concomitant therapies were not reported. Nurse called and stated that improperly stored ROTATEQ was administered to patient. No adverse effects reported. The nurse reported that vaccine dose received by patient was a vaccine improperly stored as follows: On 13-JAN-2014, ROTATEQ was stored outside of recommended temperatures for 2 hours (2 pm - 4 pm) the temperature recorded was 50 degrees F. On 18-JAN-2014, ROTATEQ was stored outside of recommended temperatures for 2 hours (2 pm - 4 pm) the temperature recorded was 49.1 degrees F. On 10-FEB-2014, ROTATEQ was stored outside of recommended temperatures for 6 hours (12 pm - 6 pm) the temperature recorded was 51.8 degrees F. On 16-FEB-2014, ROTATEQ was stored outside of recommended temperatures for 5 hours (12 pm - 5 pm) the temperature recorded was 51.8 degrees F. On 22-FEB-2014, ROTATEQ was stored outside of recommended temperatures for 4 hours (2 pm - 6 pm) the temperature recorded was 52.7 degrees F. On 09-MAR-2014, ROTATEQ was stored outside of recommended temperatures for 2 hours (12 pm - 10 pm) the temperature recorded was 55.4 degrees F. On 15-MAR-2014, ROTATEQ was stored outside of recommended temperatures for 6 hours (8 am - 2 pm) the temperature recorded was 50 degrees F. On 16-MAR-2014, ROTATEQ was stored outside of recommended temperatures for 20 hours (2 am - 10 pm) the temperature recorded was 64.4 degrees F.  On 17-MAR-2014, ROTATEQ the temperature reading on the morning was 64.8 degrees F. The total of hours stored outside of recommended temperatures was 55 hours. This is one of several reports from the same reporter. Additional information has been requested.
Pt fainted when leaving exam room, lasted few seconds, recovered after 15 min-juice and snack provided.
Chills; Sore throat; Fatigue; This is a spontaneous report from a contactable physician. A 51-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 13Feb2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. On On 13Feb2021, the patient experienced sore throat, fatigue and chills which was persisting for more than 10 days after the vaccination. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore throat, fatigue and chills was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Feeling very tingly to numb in hands and feet, and legs feel week and tingly as well. Very dizzy and when I try to do anything active, I get very faint where I feel like I'm going to pass out.
Received his anthrax vaccine (6) in his arm in the triceps area. He describes this anthrax vaccine as feeling 'different' in that with the first five anthrax vaccines, he noted a burning sensation and just after immunization. He denies any unusual or prolonged vaccines sites reactions or systemic symptoms after any use of his first five anthrax vaccine. With his sixth anthrax vaccine, he experienced the usual burning sensation with injection plus a 'real sharp pain that never went away' and that went' right to my elbow'. For two days, the elbow ached constantly and then resolved. He did not note any redness, swelling or increased warmth at the elbow. He did not experience any numbness or tingling in that extremity. There was no persistent subcutaneous nodule. After the first 2 days, he continued to experience pain described as 'knife-life pain' that is noted 'when there is something pressing against the elbow' or as 'sensitive to touch'. He rates the level of pain intensity as a level 7-8/10 using a pain scale from 0 (=no pain) to 10 (=worst pain ever experienced). Joint Pain, isolated right elbow
This case was reported by a nurse via call center representative and described the occurrence of encephalopathy in a 39-year-old female patient who received BOOSTRIX (batch number B7PC3, expiry date 12th September 2016). Concurrent medical conditions included sulfonamide allergy (caused rash), allergic reaction to antibiotics (use of MACROBID caused rash) and allergic reaction to antibiotics (AUGMENTIN). Concomitant products included DEPO-PROVERA. On 10th August 2015, the patient received BOOSTRIX .5 ml. On 3rd September 2015, 24 days after receiving BOOSTRIX, the patient experienced encephalopathy (serious criteria hospitalization and GSK medically significant), dizziness (serious criteria hospitalization), neck pain (serious criteria hospitalization) and headache (serious criteria hospitalization). On an unknown date, the outcome of the encephalopathy, dizziness, neck pain and headache were recovering/resolving. It was unknown if the reporter considered the encephalopathy and headache to be related to BOOSTRIX. The reporter considered the dizziness and neck pain to be possibly related to BOOSTRIX. Additional details were provided as follows: The BOOSTRIX was given in left deltoid. The patient was hospitalized for four days. She was doing much better, but still had some slight headaches and dizziness.
On November 2nd, 2022 I began to experience symptoms of body aches and sinus congestion by November 5th 2022 in the evening I started PAXLOVID and I began to feel well on the 6th and 7th of November by the 8th symptoms returned and by the 11th I had body aches and more sinus drainage on the 14th I went to see my doctor who prescribed and inhaler and prednisone for five days. As of the reporting date I no longer have body aches just sinus drainage and continue to use my inhaler a few times daily.
Metallic taste in mouth for last 2+ weeks. Also been experiencing a tingling sensation in both legs for last 2+ weeks, some also in arms, but mostly in legs.